Xiaodan Huang

发表

Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis

Ying Yang, Tianyou Wang, Zhigang Li, 2022, Orphanet Journal of Rare Diseases.

Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity

Zhengfan Jiang, Yuanzhong Wu, Ruhua Zhang, 2022, Cell Research.

A large, single‐center, real‐world study of clinicopathological characteristics and treatment in advanced ALK‐positive non‐small‐cell lung cancer

Y. Huang, Li Zhang, W. Fang, 2017, Cancer medicine.

The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer

Y. Huang, Likun Chen, Li Zhang, 2017, Journal of Cancer.

Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials.

Y. Huang, Li Zhang, Hongyun Zhao, 2017, Clinical lung cancer.

The efficacy and toxicity of afatinib in advanced EGFR-positive non-small-cell lung cancer patients after failure of first-generation tyrosine kinase inhibitors: a systematic review and meta-analysis.

Y. Huang, Fang Wang, Li Zhang, 2017, Journal of thoracic disease.

Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making

Jia Kou, Yuxin Liu, Y. Ouyang, 2023, Journal of Cancer Research and Clinical Oncology.

Targeting the KRT16-vimentin axis for metastasis in lung cancer.

N. Chen, Xiaofeng Pei, Hongtao Chen, 2023, Pharmacological Research.

Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials.

Li Zhang, Hongyun Zhao, Zhonghan Zhang, 2017, Clinical lung cancer.